Fertilization and pregnancies following intracytoplasmic injection of testicular spermatozoa

Purpose Intracytoplasmic injection (ICSI) with testicular sperm was performed in 16 couples. All men had ductal obstruction and failed previous attempts of epididymal sperm microaspiration.Methods Testis tissue was obtained by excisional biopsies and incubated in HEPES buffered EBSS medium over 24 h at 37C. Motile sperm (Grade 1 to 2) were recovered in 13 patients and fertilized a total of 62 oozytes. Four pregnancies were achieved.Results One healthy boy and two girls (twin pregnancy) were born.Conclusions The ongoing pregnancies revealed no fetal abnormalities on ultrasound scanning.Presented at the IXth World Congress on In Vitro Fertilization and Alternate Assisted Reproduction, April 3–7, 1995, Vienna, Austria.     

Meiotic abnormalities and spermatogenic parameters in severe oligoasthenozoospermia

The incidence of meiotic abnormalities and their relationship with different spermatogenic parameters was assessed in 103 male patients with presumably idiopathic severe oligoasthenozoospermia (motile sperm concentration < or = 1.5 x 10(6)/ml). Meiosis on testicular biopsies was independently evaluated by two observers. Meiotic patterns included normal meiosis and two meiotic abnormalities, i.e. severe arrest and synaptic anomalies. A normal pattern was found in 64 (62.1%), severe arrest in 21 (20.4%) and synaptic anomalies in 18 (17.5%). The overall rate of meiotic abnormalities was 37.9%. Most (66.7%) meiotic abnormalities occurred in patients with a sperm concentration < or = 1 x 10(6)/ml. In this group, total meiotic abnormalities were found in 57.8% of the patients; of these, 26.7% had synaptic anomalies. When the sperm concentration was < or = 0.5 x 10(6)/ml, synaptic anomalies were detected in 40% of the patients. In patients with increased follicle stimulating hormone (FSH) concentrations, total meiotic abnormalities occurred in 54.8% (synaptic anomalies in 22.6%). There were statistically significant differences among the three meiotic patterns in relation to sperm concentration (P < 0.001) and serum FSH concentration (P < 0.05). In the multivariate analysis, sperm concentration < or = 1 x 10(6)/ml and/or FSH concentration > 10 IU/l were the only predictors of meiotic abnormalities.     

Pharmacokinetics of methotrexate in leukemia cells: Effect of dose and mode of injection

A lumped compartmental model has been derived to predict methotrexate concentration as a function of time for L1210 cells in BD2F ₁ female mice at doses ranging from 3 mg/kg to 400 mg/kg. Using standard methods of parameter estimation as well as experimental determinations, an integrated approach was derived to account for the differences between the subcutaneous (s.c.) and intraperitoneal (i.p.) modes of injection. It was found that a single generalized forcing function can be used to fit plasma concentration after s.c. injection for all doses. Adequate fits (average error<20% while the standard deviation of experimental determinations was±22%) of L1210 cell data after s.c. injection were obtained. The best results were for a maximum facilitated influx constant V_max of 0.424 g/min/ml, a Michaelis influx constant K_m of 1,42 g/ml, and a first-order efflux constant of 0.047 min^–1.The model simulations were not sensitive to V_max, K_m,and so long as the ratio V_max/was approximately 9g/ml. The values of V _max ,K _m ,and which were obtained from our analysis of the in vivodata can be explained on the basis of previously performed in vitroexperiments. The parameters obtained from modeling the s.c. data were then applied for i.p. injection data. The resulting fits were adequate (average error<20% while the standard deviation of experimental determinations was±22%). A single generalized forcing function for drug concentration in the peritoneal cavity after i.p. injection for all doses was derived. The application of these results enables the prediction of methotrexate concentration in neoplastic cells at other doses after either s.c. or i.p. injection.     

Innervation of Entorhinal Principal Cells by Neurons of the Nucleus Reuniens Thalami. Anterograde PHA-L Tracing Combined with Retrograde Fluorescent Tracing and Intracellular Injection with Lucifer Yellow in the Rat

The innervation of dendrites of identified entorhinal principal cells by fibres originating in the nucleus reuniens thalami was studied in the rat. The lectin Phaseolus vulgaris-leucoagglutinin (PHA-L, anterograde tracer) was injected into the nucleus reuniens and the fluorescent dye Fast Blue (retrograde tracer) into the hippocampus. After survival, perfusion-fixation and the preparation of brain slices, entorhinal neurons retrogradely labelled with Fast Blue were intracellularly injected with the dye Lucifer yellow to introduce a specific marker into their dendrites. The transported PHA-L and the injected Lucifer yellow were visualized through dual peroxidase immunohistochemistry. Varicosities on PHA-L labelled reuniens fibres abut ascending and descending Lucifer yellow-filled secondary dendrites of multipolar and pyramidal principal entorhinal neurons that possess either spiny or sparsely spiny dendrites, but they do not appose the perikarya of these cells. In the electron microscope, PHA-L labelled boutons in the entorhinal cortex were observed forming asymmetrical synaptic contacts with dendritic spines (50%) or shafts (50%). The results indicate that direct thalamic input occurs on dendrites of neurons in the entorhinal cortex which project to the hippocampus.     

罗通定中降解物巴马汀限量检测方法

目的：研究解决罗通定及硫酸罗通定注射液中降解物巴马汀的检测方法。方法：用薄层色谱法和紫外分光光度法限量检查样品中的巴马汀。结果：与对照品斑点大小、荧光强度比较和用吸收度限值控制均可对样品中的巴马汀进行限量检查，结果与原标准一致。结论：两方法均灵敏，专属，简便，快速。     

黄芪注射液临床应用进展

目的：对黄芪注射液临床应用及其疗效进行综述。方法：通过查阅近期国内部分期刊杂志，对黄芪注射液在肺心病、老年肺结核、脑中风、冠心病、流行性出血热、病毒性心肌炎、甲亢、肝病及肾病等临床应用新进展进行综述。结果：黄芪注射液辅助治疗上述疾病疗效满意。结论：黄芪注射液是治疗心脑血管疾病、肾病、肝病等的有效药物。     

注射用通脉灵质量标准研究

目的：对注射用通脉灵进行质量标准的研究。方法：采用薄层层析法对处方中药材进行了定性鉴别，并采用分光光度法对总黄酮进行了含量测定，采用比色法对总皂苷进行了含量测定。结果：薄层色谱分离效果好，两种方法回收率RSD均小于3％。结论：该方法较简单，重现性好，可作该制剂质量控制标准。     

注射用司帕沙星的溶血试验

目的　观察注射用司帕沙星在试管内对新西兰白兔有无溶血、凝集作用。 方法 　取规定量受试药加入 2 %兔血生理盐水混悬液中 ,观察溶血和凝集情况。 结果 　第一～六管溶液中红细胞全部下沉 ,上层液体无色澄明 ,第七管全部溶血。 结论 　注射用司帕沙星在终浓度 1mg·m L- 1时 ,对兔红细胞无溶血和凝集现象。     

2001年—2003年第1季度北京地区门诊患者降血糖用药动态分析

目的 :了解北京地区糖尿病患者的用药需求 ,并对降血糖药物进行分析。方法 :采用《医院处方分析》课题 (北京地区 )2 0 0 1年～ 2 0 0 3年每年第 1季度门诊降血糖用药的处方数据进行比较。结果与结论 :通过统计 ,北京地区糖尿病患者人数不断增多 ,且人们更多选用了新型降糖药。在临床应用中 ,口服制剂以磺酰脲类用量居主导地位 ,而α-葡萄糖苷酶抑制剂用量逐年上升 ;使用基因合成人胰岛素较动物胰岛素的用量逐年增多 ,为控制糖尿病用药及合理应用提供了依据     

穴位注射治疗周围性面神经麻痹及肌电图观察

目的　观察穴位注射治疗周围性面神经麻痹的疗效。方法　将 80例患者分为穴位注射组 5 0例和对照组 30例 ,穴位注射组采用维生素 B1 2 及维生素 B1 注射液穴位注射 ,对照组采用常规针刺 ,观察两组疗效及治疗前后面部肌电图变化。结果与结论　穴位注射组治愈率及愈显率明显高于对照组 (P<0 .0 5 ,P<0 .0 1) ,治疗后穴位注射组募集电位改善情况较对照组明显为优 (P<0 .0 5 ,P<0 .0 1)。